InsiderTrades.com logo
Warning: The Last Value Play Gone After August?
From Oxford Club   |   Ad
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward
Get the Details Now.

KPTI Insider Trading (Karyopharm Therapeutics)

Insider Ownership Percentage: 10.24%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $191,881.23

Karyopharm Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Karyopharm Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Karyopharm Therapeutics Share Price & Price History

Current Price: $5.38
Price Change: ▼ Price Decrease of -0.02 (-0.37%)
As of 05/19/2022 11:04 AM ET

This chart shows the closing price history over time for KPTI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Copper More Critical than Lithium?
From Investing Trends   |   Ad
Lithium may have grabbed the headlines as a key material in building electric vehicles (EVs). But so is copper. And copper's importance in the new green economy goes far beyond EVs. Copper is critical in building wind turbines and solar panels. It's key to power lines and upgrading the national grid. Analysts say we're facing a 10-million-ton shortfall if new copper mines are not found.
See How To Can Benefit From New Copper Discoveries

Karyopharm Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/7/2022Jatin ShahEVPSell1,704$9.86$16,801.44View SEC Filing Icon  
2/7/2022Michael KauffmanDirectorSell6,764$9.86$66,693.04View SEC Filing Icon  
2/7/2022Michael MasonCFOSell3,947$9.86$38,917.42View SEC Filing Icon  
2/7/2022Sharon ShachamInsiderSell6,707$9.86$66,131.02View SEC Filing Icon  
12/2/2021Stephen MitchenerSVPSell499$6.69$3,338.31View SEC Filing Icon  
5/7/2021Jatin ShahEVPBuy23,250$8.60$199,950.00View SEC Filing Icon  
5/6/2021Garen G. BohlinDirectorBuy4,000$7.82$31,280.004,000View SEC Filing Icon  
3/18/2021Sharon ShachamInsiderSell4,000$12.39$49,560.00920,152View SEC Filing Icon  
2/18/2021Jatin ShahEVPSell1,186$14.83$17,588.3851,791View SEC Filing Icon  
2/18/2021Sharon ShachamInsiderSell9,495$14.83$140,810.85776,452View SEC Filing Icon  
12/18/2020Mansoor Raza MirzaDirectorSell5,000$18.00$90,000.005,000View SEC Filing Icon  
12/7/2020Mansoor Raza MirzaDirectorSell20,000$16.07$321,400.0020,000View SEC Filing Icon  
12/1/2020Christopher Brett PrimianoEVPSell137,061$17.53$2,402,679.3382,647View SEC Filing Icon  
10/30/2020Tanya LewisEVPSell226$15.58$3,521.08765View SEC Filing Icon  
10/13/2020Christopher Brett PrimianoEVPSell39,271$16.86$662,109.0643,199View SEC Filing Icon  
10/12/2020Michael KauffmanCEOSell7,500$14.89$111,675.00555,122View SEC Filing Icon  
9/8/2020Christopher Brett PrimianoEVPSell10,054$14.98$150,608.9214,703View SEC Filing Icon  
8/26/2020John DemareeInsiderBuy7,500$14.54$109,050.007,500View SEC Filing Icon  
8/17/2020Michael KauffmanCEOSell1,477$15.00$22,155.00555,122View SEC Filing Icon  
7/15/2020Jatin ShahEVPSell589$19.46$11,461.9443,172View SEC Filing Icon  
7/15/2020Michael KauffmanCEOSell7,500$19.43$145,725.00555,122View SEC Filing Icon  
7/10/2020Sharon ShachamInsiderSell15,000$19.27$289,050.00
7/9/2020Michael KauffmanCEOSell7,500$19.53$146,475.00562,622View SEC Filing Icon  
6/15/2020Michael KauffmanCEOSell7,500$16.37$122,775.00555,122View SEC Filing Icon  
6/10/2020Sharon ShachamInsiderSell15,000$16.60$249,000.00
6/9/2020Michael KauffmanCEOSell7,500$18.50$138,750.00562,622View SEC Filing Icon  
4/8/2020Michael KauffmanCEOSell10,000$18.61$186,100.00565,122View SEC Filing Icon  
3/9/2020Sharon ShachamInsiderSell10,000$22.52$225,200.00766,489View SEC Filing Icon  
3/2/2020Christopher Brett PrimianoEVPSell26,500$25.37$672,305.0036,867View SEC Filing Icon  
2/19/2020Jatin ShahEVPSell1,375$16.48$22,660.0040,759View SEC Filing Icon  
2/19/2020Michael KauffmanCEOSell8,817$16.48$145,304.16555,122View SEC Filing Icon  
2/19/2020Ran FrenkelInsiderSell2,975$16.48$49,028.0036,066View SEC Filing Icon  
1/9/2020Mansoor Raza MirzaDirectorSell2,056$20.00$41,120.002,056View SEC Filing Icon  
1/9/2020Michael KauffmanCEOSell10,000$19.19$191,900.00View SEC Filing Icon  
12/27/2019Christopher Brett PrimianoEVPSell5,000$20.00$100,000.008,653View SEC Filing Icon  
12/27/2019Mansoor Raza MirzaDirectorSell2,944$20.00$58,880.002,944View SEC Filing Icon  
12/18/2019Mansoor Raza MirzaDirectorSell12,121$17.18$208,238.78View SEC Filing Icon  
12/9/2019Mansoor Raza MirzaDirectorSell10,342$17.02$176,020.8410,342View SEC Filing Icon  
12/9/2019Michael KauffmanCEOSell10,000$17.02$170,200.00539,767View SEC Filing Icon  
12/6/2019Christopher Brett PrimianoEVPSell13,000$17.45$226,850.00View SEC Filing Icon  
11/11/2019Michael KauffmanCEOSell10,000$14.76$147,600.00539,767View SEC Filing Icon  
11/11/2019Sharon ShachamInsiderSell20,000$15.60$312,000.00
11/8/2019Michael KauffmanCEOSell10,000$14.63$146,300.00539,767View SEC Filing Icon  
11/1/2019Michael KauffmanCEOSell20,000$14.17$283,400.00
11/1/2019Sharon ShachamInsiderSell10,000$12.00$120,000.00741,134View SEC Filing Icon  
9/16/2019Michael KauffmanCEOSell10,000$12.00$120,000.00539,767View SEC Filing Icon  
9/16/2019Sharon ShachamInsiderSell20,000$12.00$240,000.00
See Full Table
Copper More Critical than Lithium?
From Investing Trends   |   Ad
Lithium may have grabbed the headlines as a key material in building electric vehicles (EVs). But so is copper. And copper's importance in the new green economy goes far beyond EVs. Copper is critical in building wind turbines and solar panels. It's key to power lines and upgrading the national grid. Analysts say we're facing a 10-million-ton shortfall if new copper mines are not found.
See How To Can Benefit From New Copper Discoveries

SEC Filings (Institutional Ownership Changes) for Karyopharm Therapeutics (NASDAQ:KPTI)

67.75% of Karyopharm Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at KPTI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Karyopharm Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/18/2022BNP Paribas Arbitrage SA8,550$63K0.0%-40.7%0.011%Search for SEC Filing on Google Icon
5/17/2022Walleye Capital LLC83,078$0.61M0.0%+497.6%0.105%Search for SEC Filing on Google Icon
5/17/2022Walleye Trading LLC26,482$0.20M0.0%+728.1%0.033%Search for SEC Filing on Google Icon
5/17/2022Weiss Multi Strategy Advisers LLC27,878$0.21M0.0%-6.7%0.035%Search for SEC Filing on Google Icon
5/17/2022Quantbot Technologies LP53,300$0.39M0.0%+773.8%0.067%Search for SEC Filing on Google Icon
5/17/2022Royal Bank of Canada16,567$0.12M0.0%-46.7%0.021%Search for SEC Filing on Google Icon
5/17/2022First Republic Investment Management Inc.12,833$95K0.0%-23.1%0.016%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System89,741$0.66M0.0%-7.2%0.113%Search for SEC Filing on Google Icon
5/16/2022PDT Partners LLC30,778$0.23M0.0%N/A0.039%Search for SEC Filing on Google Icon
5/16/2022Palo Alto Investors LP5,621,533$41.43M3.2%+2.8%7.078%Search for SEC Filing on Google Icon
5/16/2022Wellington Management Group LLP196,342$1.45M0.0%-2.6%0.247%Search for SEC Filing on Google Icon
5/16/2022State Street Corp10,966,701$80.83M0.0%+98.9%13.809%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG518,460$3.82M0.0%+94.2%0.653%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC215,100$1.59M0.0%+150.4%0.271%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp764,335$5.63M0.0%-1.4%0.962%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.194,197$1.43M0.0%+3.2%0.245%Search for SEC Filing on Google Icon
5/13/2022American International Group Inc.35,745$0.26M0.0%-6.6%0.045%Search for SEC Filing on Google Icon
5/13/2022Baird Financial Group Inc.17,037$0.13M0.0%-14.0%0.021%Search for SEC Filing on Google Icon
5/13/2022Candriam Luxembourg S.C.A.1,335,026$9.84M0.1%+52.1%1.681%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.3,960,708$29.19M0.0%+17.9%4.987%Search for SEC Filing on Google Icon
5/13/2022Allianz Asset Management GmbH163,985$1.21M0.0%-12.4%0.206%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.7,927,618$58.43M0.0%-11.1%9.982%Search for SEC Filing on Google Icon
5/12/2022Rhumbline Advisers79,123$0.58M0.0%-16.5%0.100%Search for SEC Filing on Google Icon
5/12/2022Metropolitan Life Insurance Co NY4,812$35K0.0%-62.9%0.006%Search for SEC Filing on Google Icon
5/12/2022MetLife Investment Management LLC41,772$0.31M0.0%+54.7%0.053%Search for SEC Filing on Google Icon
5/12/2022Acadian Asset Management LLC498,922$3.67M0.0%N/A0.628%Search for SEC Filing on Google Icon
5/12/2022Capital Fund Management S.A.44,154$0.33M0.0%N/A0.056%Search for SEC Filing on Google Icon
5/12/2022E Fund Management Co. Ltd.40,582$0.30M0.0%+227.5%0.051%Search for SEC Filing on Google Icon
5/12/2022Citigroup Inc.127,780$0.94M0.0%-58.0%0.161%Search for SEC Filing on Google Icon
5/12/2022Running Point Capital Advisors LLC10,000$74K0.0%N/A0.013%Search for SEC Filing on Google Icon
5/12/2022Blueshift Asset Management LLC22,229$0.16M0.0%N/A0.028%Search for SEC Filing on Google Icon
5/10/2022ProShare Advisors LLC21,299$0.16M0.0%-19.2%0.027%Search for SEC Filing on Google Icon
5/10/2022Aaron Wealth Advisors LLC2,837$0.39M0.0%N/A0.004%Search for SEC Filing on Google Icon
5/9/2022Swiss National Bank160,750$1.19M0.0%+7.6%0.202%Search for SEC Filing on Google Icon
5/6/2022Los Angeles Capital Management LLC18,680$0.14M0.0%N/A0.024%Search for SEC Filing on Google Icon
5/6/2022IndexIQ Advisors LLC53,438$0.39M0.0%N/A0.067%Search for SEC Filing on Google Icon
5/5/2022Rice Hall James & Associates LLC1,344,929$9.91M0.4%+5.3%1.693%Search for SEC Filing on Google Icon
5/5/2022New York State Common Retirement Fund52,425$0.39M0.0%+23.1%0.066%Search for SEC Filing on Google Icon
5/4/2022ClariVest Asset Management LLC59,600$0.44M0.0%N/A0.075%Search for SEC Filing on Google Icon
5/4/2022Victory Capital Management Inc.197,570$1.46M0.0%N/A0.249%Search for SEC Filing on Google Icon
4/27/2022Dupont Capital Management Corp22,727$0.17M0.0%-56.6%0.029%Search for SEC Filing on Google Icon
4/26/2022Hennion & Walsh Asset Management Inc.385,837$2.84M0.2%-2.0%0.486%Search for SEC Filing on Google Icon
4/21/2022Zurcher Kantonalbank Zurich Cantonalbank 10,641$78K0.0%+78.0%0.013%Search for SEC Filing on Google Icon
4/14/2022Frontier Capital Management Co. LLC1,279,295$9.43M0.1%-24.1%1.611%Search for SEC Filing on Google Icon
3/17/2022American Trust12,554$81K0.0%N/A0.017%Search for SEC Filing on Google Icon
3/3/2022Walleye Capital LLC13,903$89K0.0%N/A0.018%Search for SEC Filing on Google Icon
2/25/2022AlphaCentric Advisors LLC140,000$0.90M0.3%N/A0.185%Search for SEC Filing on Google Icon
2/23/2022Barclays PLC181,752$1.17M0.0%+37.3%0.241%Search for SEC Filing on Google Icon
2/23/2022BlackRock Inc.8,918,206$57.34M0.0%+1.5%11.805%Search for SEC Filing on Google Icon
2/19/2022Wells Fargo & Company MN65,868$0.42M0.0%+159.4%0.087%Search for SEC Filing on Google Icon
2/19/2022Weiss Multi Strategy Advisers LLC29,883$0.19M0.0%-12.4%0.040%Search for SEC Filing on Google Icon
2/16/2022Allianz Asset Management GmbH187,101$1.21M0.0%+40.7%0.248%Search for SEC Filing on Google Icon
2/16/2022The Manufacturers Life Insurance Company 38,301$0.25M0.0%-2.2%0.051%Search for SEC Filing on Google Icon
2/16/2022Deutsche Bank AG47,966$0.31M0.0%-78.6%0.063%Search for SEC Filing on Google Icon
2/16/2022California State Teachers Retirement System96,698$0.62M0.0%+9.9%0.128%Search for SEC Filing on Google Icon
2/16/2022Parametric Portfolio Associates LLC277,519$1.78M0.0%-5.3%0.367%Search for SEC Filing on Google Icon
2/15/2022Metropolitan Life Insurance Co NY12,980$83K0.0%+12.5%0.017%Search for SEC Filing on Google Icon
2/15/2022MetLife Investment Management LLC27,007$0.17M0.0%+182.6%0.036%Search for SEC Filing on Google Icon
2/15/2022Rubric Capital Management LP2,782,443$17.89M0.8%-17.6%3.683%Search for SEC Filing on Google Icon
2/15/2022Legal & General Group Plc31,845$0.21M0.0%+6.0%0.042%Search for SEC Filing on Google Icon
2/15/2022Marshall Wace LLP9,006$57K0.0%N/A0.012%Search for SEC Filing on Google Icon
2/15/2022Millennium Management LLC1,520,224$9.78M0.0%N/A2.012%Search for SEC Filing on Google Icon
2/15/2022Cubist Systematic Strategies LLC563,530$3.62M0.0%+487.0%0.746%Search for SEC Filing on Google Icon
2/14/2022D. E. Shaw & Co. Inc.176,051$1.13M0.0%N/A0.233%Search for SEC Filing on Google Icon
2/14/2022Lombard Odier Asset Management Switzerland SA1,658,047$10.66M0.7%+9.2%2.195%Search for SEC Filing on Google Icon
2/14/2022Squarepoint Ops LLC124,274$0.80M0.0%N/A0.164%Search for SEC Filing on Google Icon
2/14/2022Rice Hall James & Associates LLC1,276,634$8.21M0.3%-8.9%1.690%Search for SEC Filing on Google Icon
2/14/2022Credit Suisse AG62,143$0.40M0.0%-97.6%0.082%Search for SEC Filing on Google Icon
2/14/2022State Street Corp5,513,680$35.45M0.0%-31.3%7.298%Search for SEC Filing on Google Icon
2/14/2022Nuveen Asset Management LLC1,184,310$6.72M0.0%+5.8%1.568%Search for SEC Filing on Google Icon
2/14/2022Barclays PLC181,752$1.17M0.0%+37.3%0.241%Search for SEC Filing on Google Icon
2/14/2022GSA Capital Partners LLP191,976$1.23M0.2%+8.5%0.254%Search for SEC Filing on Google Icon
2/14/2022Invesco Ltd.31,568$0.20M0.0%-7.6%0.042%Search for SEC Filing on Google Icon
2/11/2022Geode Capital Management LLC1,442,731$9.28M0.0%+2.5%1.910%Search for SEC Filing on Google Icon
2/11/2022Renaissance Technologies LLC85,900$0.55M0.0%-82.7%0.114%Search for SEC Filing on Google Icon
2/11/2022Ensign Peak Advisors Inc43,380$0.28M0.0%N/A0.057%Search for SEC Filing on Google Icon
2/11/2022Allianz Asset Management GmbH187,101$1.21M0.0%+40.7%0.248%Search for SEC Filing on Google Icon
2/10/2022Candriam Luxembourg S.C.A.877,668$5.64M0.0%+22.3%1.162%Search for SEC Filing on Google Icon
2/10/2022Bridgefront Capital LLC24,396$0.16M0.2%+16.5%0.032%Search for SEC Filing on Google Icon
2/10/2022Rhumbline Advisers94,710$0.61M0.0%-1.5%0.125%Search for SEC Filing on Google Icon
2/10/2022Rafferty Asset Management LLC380,568$2.45M0.0%+2.6%0.504%Search for SEC Filing on Google Icon
2/10/2022Citigroup Inc.304,098$1.96M0.0%+25.0%0.403%Search for SEC Filing on Google Icon
2/10/2022Teacher Retirement System of Texas13,107$84K0.0%N/A0.017%Search for SEC Filing on Google Icon
2/9/2022Principal Financial Group Inc.12,172$78K0.0%-59.9%0.016%Search for SEC Filing on Google Icon
2/9/2022BNP Paribas Arbitrage SA14,424$93K0.0%-96.9%0.019%Search for SEC Filing on Google Icon
2/9/2022Fox Run Management L.L.C.15,443$99K0.1%N/A0.020%Search for SEC Filing on Google Icon
2/9/2022Baird Financial Group Inc.19,817$0.13M0.0%+12.1%0.026%Search for SEC Filing on Google Icon
2/8/2022Bank of America Corp DE254,868$1.64M0.0%+8.0%0.337%Search for SEC Filing on Google Icon
2/8/2022Swiss National Bank149,450$0.96M0.0%+13.5%0.198%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp775,551$4.99M0.0%+1.1%1.027%Search for SEC Filing on Google Icon
2/7/2022SG Americas Securities LLC23,716$0.15M0.0%-43.8%0.031%Search for SEC Filing on Google Icon
2/7/2022GFG Capital LLC41,400$0.27M0.1%-22.1%0.055%Search for SEC Filing on Google Icon
2/7/2022North Star Investment Management Corp.20,000$0.13M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/4/2022Arizona State Retirement System18,288$0.12M0.0%+11.8%0.024%Search for SEC Filing on Google Icon
2/3/2022Advisor Group Holdings Inc.5,132$33K0.0%-75.8%0.007%Search for SEC Filing on Google Icon
2/3/2022Virginia Retirement Systems ET AL43,100$0.28M0.0%-64.8%0.057%Search for SEC Filing on Google Icon
2/2/2022C WorldWide Group Holding A S1,500,000$9.65M0.1%+25.0%1.985%Search for SEC Filing on Google Icon
2/1/2022Assenagon Asset Management S.A.19,366$0.13M0.0%N/A0.026%Search for SEC Filing on Google Icon
1/31/2022Dupont Capital Management Corp52,402$0.34M0.0%-28.5%0.069%Search for SEC Filing on Google Icon
1/28/2022Allspring Global Investments Holdings LLC38,544$0.25M0.0%N/A0.051%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Karyopharm Therapeutics logo
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1. Its lead compound, include XPOVIO in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma, and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company has license agreement with Menarini Group to develop and commercialize NEXPOVIO for human oncology indications in Europe, including the United Kingdom; Latin America; and other countries. Its oral SINE compounds also designed to force nuclear accumulation in the levels of multiple tumor suppressor and growth regulatory proteins. The company was incorporated in 2008 and is headquartered in Newton, Massachusetts.
Read More on Karyopharm Therapeutics

Today's Range

Now: $5.38
Low: $5.30
High: $5.56

50 Day Range

MA: $6.86
Low: $5.05
High: $8.37

52 Week Range

Now: $5.38
Low: $4.42
High: $14.73

Volume

19,384 shs

Average Volume

2,545,540 shs

Market Capitalization

$427.28 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Karyopharm Therapeutics?

Karyopharm Therapeutics' top insider shareholders include:
  1. Sharon Shacham (Insider)
  2. Michael Kauffman (CEO)
  3. Christopher Brett Primiano (EVP)
  4. Jatin Shah (EVP)
  5. Mansoor Raza Mirza (Director)
  6. John Demaree (Insider)
  7. Garen G Bohlin (Director)
  8. Tanya Lewis (EVP)
  9. Michael Kauffman (Director)
  10. Michael Mason (CFO)
  11. Stephen Mitchener (SVP)
Learn More about top insider investors at Karyopharm Therapeutics.

Who are the major institutional investors of Karyopharm Therapeutics?

Karyopharm Therapeutics' top institutional shareholders include:
  1. State Street Corp — 13.81%
  2. BlackRock Inc. — 9.98%
  3. Palo Alto Investors LP — 7.08%
  4. Vanguard Group Inc. — 4.99%
  5. Rice Hall James & Associates LLC — 1.69%
  6. Candriam Luxembourg S.C.A. — 1.68%
Learn More about top institutional investors of Karyopharm Therapeutics stock.

Which major investors are selling Karyopharm Therapeutics stock?

Within the previous quarter, KPTI stock was sold by these institutional investors:
  1. BlackRock Inc.
  2. Frontier Capital Management Co. LLC
  3. Citigroup Inc.
  4. Group One Trading L.P.
  5. Simplex Trading LLC
  6. Dupont Capital Management Corp
  7. Allianz Asset Management GmbH
  8. Rhumbline Advisers
Within the last year, company insiders that have sold Karyopharm Therapeutics company stock include:
  1. Sharon Shacham (Insider)
  2. Michael Kauffman (CEO)
  3. Christopher Brett Primiano (EVP)
  4. Jatin Shah (EVP)
  5. Mansoor Raza Mirza (Director)
Learn More investors selling Karyopharm Therapeutics stock.

Which major investors are buying Karyopharm Therapeutics stock?

In the last quarter, KPTI stock was purchased by institutional investors including:
  1. State Street Corp
  2. Vanguard Group Inc.
  3. Acadian Asset Management LLC
  4. Candriam Luxembourg S.C.A.
  5. UBS Group AG
  6. Victory Capital Management Inc.
  7. Palo Alto Investors LP
  8. Renaissance Technologies LLC
In the previous year, these company insiders have bought Karyopharm Therapeutics stock:
  1. Sharon Shacham (Insider)
  2. Michael Kauffman (CEO)
  3. Christopher Brett Primiano (EVP)
Learn More investors buying Karyopharm Therapeutics stock.
Lithium Triangle a "Treasure Trove" for the Popular Energy Metal
From Investing Trends   |   Ad
Lithium is the most precious commodity of the green revolution, and experts predict an exploding demand for the energy metal. Surrounded by multi-billion dollar assets, one little-known small-cap company in a renowned location in South America may become a strong link in the lithium supply chain due to a monster acquisition.
Put this company on your radar now.